Lineage Cell Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. DFTX
7. GOOGL
8. MU
9. IBM
10. HOOD

Go back to Lineage Cell Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

Lineage Cell Therapeutics (LCTX) Misses Q2 EPS by 10c, Beats on Revenue

August 12, 2025 4:02 PM EDT

Lineage Cell Therapeutics (NYSE: LCTX) reported Q2 EPS of ($0.13), $0.10 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $2.77 million versus the consensus estimate of $1.48 million.

For earnings history and earnings-related data on Lineage Cell Therapeutics (LCTX) click here.

... More